Screening older cancer patients for a Comprehensive Geriatric Assessment: A comparison of three instruments

Journal of Geriatric Oncology

Volumn 2, Issue 2, 2011, Pages 121-129

  Owusu, Cynthia ^a,b   Koroukian, Siran M ^b,c   Schluchter, Mark ^b,c   Bakaki, Paul ^b,c   Berger, Nathan A ^a,b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Comprehensive Geriatric Assessment; ECOG PS; KPS; Older; Screening; VES 13

Indexed keywords

ADL DISABILITY; AGED; ARTICLE; CANCER PATIENT; CANCER SCREENING; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISCRIMINANT ANALYSIS; EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS; FEMALE; FUNCTIONAL DISEASE; GERIATRIC ASSESSMENT; HUMAN; INTERMETHOD COMPARISON; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TASK PERFORMANCE; VULNERABLE ELDERS SURVEY;

EID: 79952628117     PISSN: 18794068     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jgo.2010.12.002     Document Type: Article

References (46)

1. Yancik R. Cancer burden in the aged: an epidemiologic and demographic overview. Cancer 1997, 80:1273-1283.
2. Muss H.B. Older age-not a barrier to cancer treatment. N Engl J Med 2001, 345:1127-1128.
3. Bouchardy C., Rapiti E., Fioretta G., et al. Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol 2003, 21:3580-3587.
4. Lewis J.H., Kilgore M.L., Goldman D.P., et al. Participation of patients 65years of age or older in cancer clinical trials. J Clin Oncol 2003, 21:1383-1389.
5. National Comprehensive Cancer Network Clin Pract Guidel Sr Adult Oncol 2010, Version 1 (http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf1). Last assessed on 01/01/2011.
6. Stuck A.E., Siu A.L., Wieland G.D., et al. Comprehensive Geriatric Assessment: a meta-analysis of controlled trials. Lancet 1993, 342:1032-1036.
7. Freyer G., Geay J.F., Touzet S., et al. Comprehensive Geriatric Assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study. Ann Oncol 2005, 16:1795-1800.
8. Maione P., Perrone F., Gallo C., et al. Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol 2005, 23:6865-6872.
9. Tucci A., Ferrari S., Bottelli C., et al. A Comprehensive Geriatric Assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy. Cancer 2009, 115:4547-4553.
10. Cudennec T., Gendry T., Labrune S., et al. Use of a simplified geriatric evaluation in thoracic oncology. Lung Cancer 2010, 67:232-236.
11. Repetto L., Fratino L., Audisio R.A., et al. Comprehensive Geriatric Assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol 2002, 20:494-502.
12. Balducci L., Extermann M. Management of cancer in the older person: a practical approach. Oncologist 2000, 5:224-237.
13. Saliba D., Orlando M., Wenger N.S., et al. Identifying a short functional disability screen for older persons. J Gerontol A Biol Sci Med Sci 2000, 55:M750-M756.
14. Min L., Yoon W., Mariano J., et al. The Vulnerable Elders-13 Survey predicts 5-year functional decline and mortality outcomes in older ambulatory care patients. J Am Geriatr Soc 2009.
15. Min L.C., Elliott M.N., Wenger N.S., et al. Higher Vulnerable Elders Survey scores predict death and functional decline in vulnerable older people. J Am Geriatr Soc 2006, 54:507-511.
16. Higashi T., Shekelle P.G., Adams J.L., et al. Quality of care is associated with survival in vulnerable older patients. Ann Intern Med 2005, 143:274-281.
17. Mohile S.G., Bylow K., Dale W., et al. A pilot study of the Vulnerable Elders Survey-13 compared with the Comprehensive Geriatric Assessment for identifying disability in older patients with prostate cancer who receive androgen ablation. Cancer 2007, 109:802-810.
18. Luciani A., Ascione G., Bertuzzi C., et al. Detecting disabilities in older patients with cancer: comparison between Comprehensive Geriatric Assessment and Vulnerable Elders Survey-13. J Clin Oncol 2010, 28(12):2046-2050.
19. Albain K.S., Crowley J.J., LeBlanc M., et al. Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience. J Clin Oncol 1991, 9:1618-1626.
20. Oken M.M., Creech R.H., Tormey D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982, 5:649-655.
21. Firat S., Byhardt R.W., Gore E. Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 2002, 54:357-364.
22. Finkelstein D.M., Cassileth B.R., Bonomi P.D., et al. A pilot study of the Functional Living Index-Cancer (FLIC) scale for the assessment of quality of life for metastatic lung cancer patients. An Eastern Cooperative Oncology Group study. Am J Clin Oncol 1988, 11:630-633.
23. Karnofsky D., Burchenal J. The clinical evaluation of chemotherapeutic agents in cancer. Evaluation of chemotherapeutic agents 1948, 191-205. Columbia University Press, New York. C.M. Macleod (Ed.).
24. Manni A., Bartholomew M., Caplan R., et al. Androgen priming and chemotherapy in advanced prostate cancer: evaluation of determinants of clinical outcome. J Clin Oncol 1988, 6:1456-1466.
25. Kemeny N., Niedzwiecki D., Shurgot B., et al. Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvement. Cancer 1989, 63:742-747.
26. Ganz P.A., Haskell C.M., Figlin R.A., et al. Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the Functional Living Index-Cancer. Cancer 1988, 61:849-856.
27. Ma C., Bandukwala S., Burman D., et al. Interconversion of three measures of performance status: an empirical analysis. Eur J Cancer 2010, 46(18):3175-3183.
28. Buccheri G., Ferrigno D., Tamburini M. Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer 1996, 32A:1135-1141.
29. Katz S., Ford A.B., Moskowitz R.W., et al. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. Jama 1963, 185:914-919.
30. Lawton M.P. Scales to measure competence in everyday activities. Psychopharmacol Bull 1988, 24:609-614.
31. Teno J., Kiel D.P., Mor V. Multiple stumbles: a risk factor for falls in community-dwelling elderly. A prospective study. J Am Geriatr Soc 1990, 38:1321-1325.
32. Shumway-Cook A., Brauer S., Woollacott M. Predicting the probability for falls in community-dwelling older adults using the Timed Up & Go Test. Phys Ther 2000, 80:896-903.
33. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987, 40:373-383.
34. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
35. Crum R.M., Anthony J.C., Bassett S.S., et al. Population-based norms for the Mini-Mental State Examination by age and educational level. Jama 1993, 269:2386-2391.
36. Yesavage J.A., Brink T.L., Rose T.L., et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982, 17:37-49.
37. Jyrkka J., Enlund H., Korhonen M.J., et al. Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis. Drugs Aging 2009, 26:493-503.
38. Jyrkka J., Enlund H., Korhonen M.J., et al. Polypharmacy status as an indicator of mortality in an elderly population. Drugs Aging 2009, 26:1039-1048.
39. Lai SW, Liao KF, Liao CC, et al. Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study. Medicine (Baltimore) 89:295-9.
40. Sherbourne C.D., Stewart A.L. The MOS social support survey. Soc Sci Med 1991, 32:705-714.
41. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845.
42. Perkins N.J., Schisterman E.F. The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol 2006, 163:670-675.
43. Gridelli C., Ardizzoni A., Le Chevalier T., et al. Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel. Ann Oncol 2004, 15:419-426.
44. Kellen E., Bulens P., Deckx L., et al. Identifying an accurate pre-screening tool in geriatric oncology. Crit Rev Oncol Hematol 2010, 75:243-248.
45. Cigolle C.T., Langa K.M., Kabeto M.U., et al. Geriatric conditions and disability: the Health and Retirement Study. Ann Intern Med 2007, 147:156-164.
46. Mohile S.G., Xian Y., Dale W., et al. Association of a cancer diagnosis with vulnerability and frailty in older Medicare beneficiaries. J Natl Cancer Inst 2009, 101:1206-1215.